GO:0004175 endopeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004175 endopeptidase activity describes the catalysis of hydrolysis of internal alpha-peptide bonds in a polypeptide chain, a core molecular function executed by proteases such as matrix metalloproteinases, ADAM10, BACE1, PCSK9, and botulinum neurotoxins.
• Endopeptidases are not merely degradative enzymes; they regulate long-term potentiation, fibrinolytic physiology, and metabolic signaling, making them central to neuronal plasticity and vascular homeostasis.
• Dysregulated endopeptidase activity contributes to Alzheimer's disease through BACE1 and ADAM10 imbalance, to atherosclerosis through PCSK9 processing, and to obesity-related matrix remodeling through MMPs.
• Lactate has been shown to increase ADAM10 activity and reduce BACE1 activity in mouse brain, demonstrating that endopeptidase activity is metabolically regulated.
• Plasma PCSK9 concentration is influenced by the 24-hour activity cycle, linking endopeptidase-related biology to circadian and lifestyle factors.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of endopeptidase genes in disease-relevant cell types.
Description
Endopeptidase activity (GO:0004175) is a molecular function defined as the catalysis of hydrolysis of internal alpha-peptide bonds in a polypeptide chain. Unlike exopeptidases that trim terminal residues, endopeptidases cleave within the polypeptide backbone, generating distinct peptide fragments that can act as signaling molecules, antigens, or degradation intermediates. This activity is essential for protein turnover, extracellular matrix remodeling, and the activation or inactivation of bioactive peptides. The physiological importance of endopeptidase activity is illustrated by the fibrinolytic system, in which plasminogen activators and plasmin mediate controlled proteolysis to maintain vascular patency. In the nervous system, endopeptidases such as ADAM10 and BACE1 regulate amyloid precursor protein processing, directly influencing Alzheimer's disease pathogenesis. In metabolic and cardiovascular contexts, PCSK9 and matrix metalloproteinases (MMPs) modulate lipid homeostasis and tissue remodeling, respectively. Because endopeptidase activity is implicated in diverse pathologies, researchers require robust experimental models to determine which proteases are causally involved in specific disease processes. This article integrates QuickGO annotation data with verified PubMed literature to provide a research-grade overview of GO:0004175, its gene families, regulatory mechanisms, and CRISPR-based methods for functional interrogation.
endopeptidase activity At A Glance
| GO ID | GO:0004175 |
|---|---|
| GO term | endopeptidase activity |
| Ontology | molecular_function |
| Synonym | elastase activity, endoprotease activity, proteasome endopeptidase activity, proteinase |
| Definition | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain. |
| Major function | Proteolytic cleavage of internal peptide bonds in substrate polypeptides |
| Representative enzymes | MMPs, ADAM10, BACE1, PCSK9, botulinum neurotoxins, plasmin |
| Subcellular context | Secreted, plasma membrane, lysosomal, and cytosolic compartments depending on enzyme |
| Disease relevance | Alzheimer's disease, atherosclerosis, obesity, botulism, thrombosis |
What Is GO:0004175?
According to the Gene Ontology, GO:0004175 endopeptidase activity is the catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain. This definition distinguishes endopeptidases from exopeptidases, which act only at the termini of polypeptide chains. The term encompasses enzymes historically described as elastases, endoproteases, proteasome endopeptidases, and proteinases. Endopeptidase activity is a molecular function that can be executed by serine, cysteine, aspartic, threonine, and metalloproteases, each using distinct catalytic chemistries but sharing the ability to cleave internal peptide bonds.
Why Is endopeptidase activity Important in Cell Biology?
Endopeptidase activity is fundamental to proteostasis and signal transduction because it irreversibly modifies protein function and generates bioactive peptides. In the nervous system, the balance between ADAM10 and BACE1 endopeptidase activities determines whether amyloid precursor protein is processed toward neuroprotective or amyloidogenic pathways, directly impacting Alzheimer's disease risk. In the vasculature, plasmin-mediated endopeptidase activity governs fibrin degradation and thrombus resolution. In metabolic disease, MMPs and PCSK9 influence adipose tissue remodeling and LDL receptor recycling, respectively. Because endopeptidases are druggable and their activities are measurable, they represent high-value targets for therapeutic development and biomarker discovery.
• Regulates long-term potentiation and synaptic plasticity through protease-mediated remodeling.
• Controls fibrinolytic balance and vascular homeostasis via plasmin and related endopeptidases.
• Determines amyloidogenic versus non-amyloidogenic APP processing through BACE1 and ADAM10.
• Modulates lipid metabolism through PCSK9 autocatalytic processing and LDL receptor regulation.
• Influences obesity-associated extracellular matrix remodeling via matrix metalloproteinases.
• Mediates botulinum neurotoxin toxicity through endopeptidase cleavage of SNARE proteins.
• Provides biomarkers such as plasma PCSK9 that vary with activity cycles.
• Offers therapeutic targets for Alzheimer's disease, atherosclerosis, and metabolic disorders.
• Enables peptide hormone maturation and inactivation in endocrine and neuroendocrine systems.
• Supports immune surveillance through antigen processing and presentation.
Molecular Mechanism of endopeptidase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the target protein at a specific sequence or structural feature.
Endopeptidases recognize substrates through extended active-site clefts or exosite interactions that confer specificity. For example, botulinum neurotoxins exhibit strict substrate recognition of SNARE proteins, cleaving them at defined peptide bonds to block neurotransmitter release. Matrix metalloproteinases bind extracellular matrix components through their catalytic domains and hemopexin-like domains, which position the scissile bond for hydrolysis. ADAM10 and BACE1 recognize distinct cleavage sites within amyloid precursor protein, with ADAM10 acting at the alpha-secretase site and BACE1 at the beta-secretase site.
Catalytic hydrolysis of the peptide bond
In simple terms: Once bound, the enzyme uses water and catalytic residues to cut the protein backbone.
The hydrolysis of internal alpha-peptide bonds proceeds through nucleophilic attack on the carbonyl carbon, forming a tetrahedral intermediate that collapses to release two peptide fragments. Metalloproteases such as MMPs and botulinum neurotoxins use a zinc ion coordinated by histidine residues to activate a water molecule for nucleophilic attack. Serine proteases like plasmin use a catalytic triad to achieve the same chemistry. The reaction is energetically favorable but kinetically controlled, requiring precise substrate positioning.
Cofactors and metal ion dependence
In simple terms: Many endopeptidases need metal helpers, especially zinc, to work.
Zinc is an essential cofactor for matrix metalloproteinases and botulinum neurotoxins, where it is coordinated in the active site and directly participates in catalysis. Calcium ions contribute to structural stability and substrate binding in some MMPs. In contrast, serine endopeptidases such as plasmin do not require metal cofactors but depend on the catalytic triad. PCSK9 is a serine protease-like enzyme whose autocatalytic processing is required for its secretion and function, although its canonical role in LDL receptor degradation does not require full proteolytic activity.
Regulation by endogenous inhibitors and metabolic signals
In simple terms: The activity of these enzymes is kept in check by inhibitors and can be tuned by metabolites like lactate.
Endopeptidase activity is tightly regulated by endogenous inhibitors such as tissue inhibitors of metalloproteinases (TIMPs) for MMPs and alpha-2-antiplasmin for plasmin. Lactate has been shown to increase ADAM10 activity and reduce BACE1 activity in mouse brain, demonstrating metabolic regulation of endopeptidase function. The 24-hour activity cycle influences plasma PCSK9 concentration, suggesting circadian or behavioral modulation of PCSK9-related endopeptidase biology. Irisin, a myokine, has been implicated in multiorgan protection that may involve modulation of proteolytic pathways.
Downstream consequences of cleavage
In simple terms: Cutting a protein can activate it, destroy it, or turn it into a signal.
Endopeptidase activity generates products with distinct biological functions. Cleavage of amyloid precursor protein by BACE1 releases sAPPbeta and C99, which are amyloidogenic, whereas ADAM10 cleavage releases neuroprotective sAPPalpha. Plasmin-mediated cleavage of fibrin yields degradation products that report on fibrinolytic activity. Botulinum neurotoxin cleavage of SNARE proteins produces a dominant-negative fragment that inhibits vesicle fusion. MMP cleavage of extracellular matrix components releases bioactive fragments that can promote inflammation or angiogenesis.
Key Genes Involved in GO:0004175 endopeptidase activity
The following genes encode representative endopeptidases or proteins that regulate endopeptidase activity, based on verified literature linking them to GO:0004175.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MMP1 | Matrix metalloproteinase that degrades interstitial collagen | Implicated in exercise and obesity-related tissue remodeling |
| MMP2 | Gelatinase A; degrades type IV collagen | Studied in extracellular matrix turnover and metabolic disease |
| MMP9 | Gelatinase B; degrades denatured collagen | Linked to inflammation and obesity-associated remodeling |
| ADAM10 | Alpha-secretase; cleaves APP at non-amyloidogenic site | Neuroprotective; activity increased by lactate in mouse brain |
| BACE1 | Beta-secretase; cleaves APP at amyloidogenic site | Central to Alzheimer's disease; activity reduced by lactate |
| PCSK9 | Proprotein convertase; regulates LDL receptor | Target for cholesterol lowering; plasma levels vary with activity cycle |
| PLG | Plasminogen; precursor of plasmin endopeptidase | Key to fibrinolysis and vascular homeostasis |
| PLAT | Tissue plasminogen activator; activates plasminogen | Regulates fibrinolytic endopeptidase cascade |
| PLAU | Urokinase plasminogen activator | Involved in tissue remodeling and cell migration |
| SERPINE1 | PAI-1; inhibits plasminogen activators | Modulates fibrinolytic endopeptidase activity |
| F2 | Thrombin; serine endopeptidase in coagulation | Links coagulation to fibrinolytic system |
| FNDC5 | Irisin precursor; cleaved to release irisin | Multiorgan protection involving proteolytic processing |
| BOTOX_LIKE | Botulinum neurotoxin light chain; cleaves SNARE proteins | Endopeptidase activity in botulism pathogenesis |
| TIMP1 | Inhibitor of MMPs | Regulates MMP endopeptidase activity |
| TIMP2 | Inhibitor of MMPs | Regulates MMP endopeptidase activity |
| LDLR | LDL receptor; degraded by PCSK9 | Endopeptidase-regulated cholesterol uptake |
| APP | Amyloid precursor protein; substrate of ADAM10 and BACE1 | Central to Alzheimer's disease research |
How Is endopeptidase activity Regulated?
Endopeptidase activity is regulated at multiple levels. Transcriptional control determines enzyme abundance, as seen with MMPs induced by inflammatory cytokines or mechanical load. Post-translational activation, such as plasminogen cleavage by tPA or uPA, converts zymogens into active endopeptidases. Endogenous inhibitors including TIMPs and serpins provide rapid, reversible or irreversible inhibition. Metabolic signals such as lactate can acutely modulate ADAM10 and BACE1 activities in the brain. The 24-hour activity cycle influences plasma PCSK9 concentration, suggesting circadian or behavioral regulation of PCSK9-related endopeptidase biology. Irisin, a cleavage product of FNDC5, may feed back on proteolytic pathways in the context of multiorgan protection.
endopeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BACE1 | Alzheimer's disease; amyloidogenic APP processing | Knockout or point-mutation in neuronal cell lines; APP processing assays |
| ADAM10 | Alzheimer's disease; neuroprotective APP processing | Overexpression or knock-in of active-site mutants in neurons |
| PCSK9 | Atherosclerosis; LDL receptor degradation | Knockout hepatocytes; LDL uptake assays; point mutations in catalytic domain |
| MMP9 | Obesity; extracellular matrix remodeling | Knockout or overexpression in adipocytes; matrix degradation assays |
| PLG | Thrombosis; fibrinolysis | Knockout or point-mutation in hepatocytes; plasmin generation assays |
Alzheimer's disease and amyloidogenic processing
In Alzheimer's disease, the balance between ADAM10 and BACE1 endopeptidase activities determines whether amyloid precursor protein is processed via the non-amyloidogenic or amyloidogenic pathway. BACE1 cleavage generates amyloid-beta peptides that aggregate into plaques, whereas ADAM10 cleavage precludes amyloid-beta production. Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain, suggesting that metabolic interventions could shift this balance. Proteases involved in long-term potentiation also contribute to synaptic plasticity, and their dysregulation may impair memory.
Atherosclerosis and PCSK9 biology
PCSK9 is a secreted endopeptidase-like protein that binds the LDL receptor and promotes its lysosomal degradation, thereby reducing LDL clearance and raising plasma cholesterol. Plasma PCSK9 concentration is influenced by the 24-hour activity cycle, indicating that lifestyle and circadian factors modulate this endopeptidase-related pathway. Inhibiting PCSK9 function lowers LDL cholesterol and reduces cardiovascular risk, making PCSK9 a major therapeutic target.
Obesity and matrix remodeling
Matrix metalloproteinases are endopeptidases that remodel the extracellular matrix in adipose tissue and skeletal muscle. Exercise and obesity alter MMP expression and activity, influencing tissue fibrosis, inflammation, and insulin sensitivity. TIMPs counterbalance MMP activity, and an imbalance can contribute to pathological remodeling.
Botulism and neurotoxin endopeptidase activity
Botulinum neurotoxins are zinc-dependent endopeptidases that cleave SNARE proteins, preventing neurotransmitter release and causing flaccid paralysis. The endopeptidase activity of the botulinum toxin light chain is essential for its toxicity, and understanding this activity informs vaccine and therapeutic development.
From endopeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BACE1 endopeptidase activity reduce amyloid-beta production? | BACE1 knockout neuronal cell line |
| Does a specific point mutation in the ADAM10 catalytic site abolish alpha-secretase activity? | ADAM10 point-mutation knock-in |
| Can a tagged PCSK9 knock-in track secretion and LDL receptor binding? | Tagged PCSK9 knock-in hepatocytes |
| Does overexpression of MMP9 increase matrix degradation in adipocytes? | MMP9 overexpression in 3T3-L1 adipocytes |
| Does knockout of PLG impair fibrinolysis? | PLG knockout hepatocytes or mouse models |
| Does a disease-associated variant in PCSK9 alter autocatalytic processing? | PCSK9 point-mutation knock-in |
How to Study the endopeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic peptide assay | Endopeptidase catalytic activity | Measure ADAM10 or BACE1 activity in cell lysates |
| Gelatin zymography | MMP activity | Assess MMP2/MMP9 in conditioned media |
| Western blot | Substrate cleavage products | Detect sAPPalpha/beta or fibrin degradation |
| CRISPR knockout screen | Genes regulating endopeptidase activity | Identify modifiers of protease sensitivity |
| TAILS proteomics | Natural endopeptidase substrates | Map degradome in disease models |
| ELISA | Plasma PCSK9 concentration | Study activity cycle effects |
| FRET-based live imaging | Real-time endopeptidase activity | Monitor protease activity in live cells |
| Bioinformatics pathway analysis | Enrichment of proteolytic pathways | Interpret CRISPR screen hits |
Protease activity assays
Fluorogenic or colorimetric peptide substrates are used to measure endopeptidase activity in cell lysates or conditioned media. For example, ADAM10 and BACE1 activities can be quantified using specific FRET peptides that emit fluorescence upon cleavage. MMP activity can be measured using gelatin zymography or fluorogenic substrates. These assays provide direct functional readouts of GO:0004175.
Western blotting and substrate cleavage analysis
Western blotting detects cleavage products of known substrates, such as sAPPalpha and sAPPbeta from APP, or fibrin degradation products from plasmin. Antibodies against neoepitopes generated by cleavage can confirm specific endopeptidase activity. This method is widely used to validate knockout or inhibitor effects.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate endopeptidase activity or sensitivity to protease inhibitors. Libraries targeting proteases and their regulators enable unbiased discovery of pathways controlling GO:0004175. Bioinformatics analysis of screen hits can reveal enrichment of proteolytic cascades.
Proteomics and degradomics
Mass spectrometry-based proteomics, including terminal amine isotopic labeling of substrates (TAILS), identifies natural endopeptidase substrates and cleavage sites. This approach maps the degradome and reveals how endopeptidase activity reshapes the proteome in disease states.
How CRISPR Can Be Used to Study GO:0004175 endopeptidase activity
Knockout
CRISPR knockout of endopeptidase genes such as BACE1, ADAM10, or MMP9 eliminates enzyme activity and allows assessment of substrate accumulation or loss of cleavage products. For example, BACE1 knockout neurons show reduced amyloid-beta production. Knockout models are essential for establishing causality in GO:0004175-related pathways.
Point Mutation
Point mutations in catalytic residues (e.g., zinc-binding histidines in MMPs or the catalytic serine in PCSK9) can abolish endopeptidase activity while preserving protein expression and localization. Such models distinguish catalytic activity from non-catalytic functions, as seen with PCSK9 mutants that affect LDL receptor degradation.
Knock-in
Knock-in of disease-associated variants or tagged versions of endopeptidase genes enables tracking of enzyme localization, secretion, and substrate processing. For example, a tagged PCSK9 knock-in can monitor autocatalytic processing and secretion. Knock-in of APP mutations alters susceptibility to ADAM10 or BACE1 cleavage.
Overexpression
Overexpression of endopeptidases such as MMP9 or ADAM10 increases cleavage of substrates and can model pathological states like matrix degradation or enhanced alpha-secretase activity. Overexpression models are useful for gain-of-function studies and for testing inhibitors.
How EDITGENE Supports endopeptidase activity Research
Researchers studying endopeptidase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides CRISPR-based cell models and screening services to enable such causal inference with high precision.
Contact EDITGENE today to design your custom CRISPR model for endopeptidase activity research.
Frequently Asked Questions About endopeptidase activity
What is endopeptidase activity?
Endopeptidase activity (GO:0004175) is the catalysis of hydrolysis of internal alpha-peptide bonds in a polypeptide chain, as defined by the Gene Ontology.
What genes are involved in endopeptidase activity?
Genes encoding endopeptidases include MMP1, MMP2, MMP9, ADAM10, BACE1, PCSK9, PLG, PLAT, and PLAU, among others.
How is endopeptidase activity measured?
It is measured using fluorogenic peptide substrates, zymography, Western blotting of cleavage products, and proteomics methods such as TAILS.
What diseases are linked to endopeptidase activity?
Alzheimer's disease, atherosclerosis, obesity, thrombosis, and botulism are linked to dysregulated endopeptidase activity.
How does lactate affect endopeptidase activity?
Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain.
What is the role of PCSK9 as an endopeptidase?
PCSK9 is a secreted protease-like protein that promotes LDL receptor degradation, and its plasma concentration varies with the 24-hour activity cycle.
Can CRISPR be used to study endopeptidase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of endopeptidase genes.
What are matrix metalloproteinases?
MMPs are zinc-dependent endopeptidases that degrade extracellular matrix components and are involved in exercise and obesity-related remodeling.
How does botulinum toxin relate to endopeptidase activity?
Botulinum neurotoxins are zinc-dependent endopeptidases that cleave SNARE proteins, causing paralysis.
What is the fibrinolytic system?
The fibrinolytic system is a proteolytic cascade in which plasmin, generated by plasminogen activators, degrades fibrin to maintain vascular patency.
Conclusion
GO:0004175 endopeptidase activity is a fundamental molecular function that governs protein processing, signal transduction, and tissue remodeling. Its dysregulation is implicated in Alzheimer's disease, atherosclerosis, obesity, and thrombosis, making it a high-priority target for therapeutic intervention. CRISPR-based models and functional screens provide powerful tools to dissect the causal roles of individual endopeptidases and their regulators. EDITGENE offers comprehensive services to support such research.
References
- 1. Majou D. 2024. Endopeptidase activities of Clostridium botulinum toxins in the development of this bacterium.. Res Microbiol 175(7):104216 PMID: 38897423
- 2. Moberg I et al.. 2024. Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain.. J Physiol 602(20):5217-5228 PMID: 39298105
- 3. Kuo WC et al.. 2020. Does 24-h Activity Cycle Influence Plasma PCSK9 Concentration? A Systematic Review and Meta-Analysis.. Curr Atheroscler Rep 22(7):30 PMID: 32542587
- 4. Ma J et al.. 2021. The role of Irisin in multiorgan protection.. Mol Biol Rep 48(1):763-772 PMID: 33389537
- 5. Jaoude J et al.. 2016. Matrix metalloproteinases in exercise and obesity.. Vasc Health Risk Manag 12:287-95 PMID: 27471391
- 6. Tomimatsu Y et al.. 2002. Proteases involved in long-term potentiation.. Life Sci 72(4-5):355-61 PMID: 12467876
- 7. Takada A et al.. 1993. The physiology of the fibrinolytic system.. Jpn J Physiol 43(1):1-19 PMID: 8336419
- 8. Cui CJ et al.. 2015. PCSK9 and its modulation.. Clin Chim Acta 440:79-86 PMID: 25444750
